PUTRAJAYA, Feb 8 — The company that has been granted conditional registration approval for Lagevrio for the treatment of Covid-19 must submit the latest safety data from time to time through rolling submission to the National Pharmaceutical Regulatory Agency (NPRA), said its director Rosilawati Ahmad.

NEW YORK, Dec 14 — Pfizer Inc on Tuesday said final analysis of its antiviral Covid-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus.